ADC Therapeutics SA (ADCT)
4.135
+0.10
(+2.35%)
USD |
NYSE |
May 15, 14:43
ADC Therapeutics Price: 4.135 for May 15, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 14, 2024 | 4.23 | 4.28 | 3.80 | 4.04 | 638496.0 |
| May 13, 2024 | 4.27 | 4.43 | 4.18 | 4.19 | 218612.0 |
| May 10, 2024 | 4.56 | 4.58 | 4.03 | 4.30 | 1.172M |
| May 09, 2024 | 4.47 | 4.68 | 4.40 | 4.57 | 329931.0 |
| May 08, 2024 | 4.71 | 4.83 | 4.375 | 4.41 | 517405.0 |
| May 07, 2024 | 4.40 | 4.91 | 4.32 | 4.83 | 886012.0 |
| May 06, 2024 | 4.82 | 5.17 | 4.42 | 4.45 | 3.364M |
| May 03, 2024 | 4.96 | 5.105 | 4.81 | 4.90 | 323274.0 |
| May 02, 2024 | 4.74 | 4.75 | 4.40 | 4.73 | 279094.0 |
| May 01, 2024 | 4.44 | 4.85 | 4.35 | 4.71 | 398991.0 |
| Apr 30, 2024 | 4.47 | 4.58 | 4.35 | 4.41 | 220813.0 |
| Apr 29, 2024 | 4.37 | 4.73 | 4.30 | 4.50 | 242225.0 |
| Apr 26, 2024 | 4.44 | 4.51 | 4.21 | 4.34 | 323499.0 |
| Apr 25, 2024 | 4.65 | 4.65 | 4.41 | 4.44 | 297280.0 |
| Apr 24, 2024 | 4.99 | 5.00 | 4.71 | 4.78 | 276687.0 |
| Apr 23, 2024 | 4.72 | 5.08 | 4.72 | 4.97 | 402955.0 |
| Apr 22, 2024 | 4.79 | 4.79 | 4.56 | 4.68 | 173368.0 |
| Apr 19, 2024 | 4.76 | 4.92 | 4.60 | 4.72 | 646031.0 |
| Apr 18, 2024 | 4.95 | 4.95 | 4.72 | 4.76 | 278551.0 |
| Apr 17, 2024 | 4.52 | 5.02 | 4.49 | 4.96 | 1.272M |
| Apr 16, 2024 | 4.33 | 4.60 | 4.305 | 4.44 | 238230.0 |
| Apr 15, 2024 | 4.39 | 4.47 | 4.11 | 4.37 | 464878.0 |
| Apr 12, 2024 | 4.71 | 4.749 | 4.31 | 4.39 | 337039.0 |
| Apr 11, 2024 | 4.77 | 4.86 | 4.52 | 4.68 | 401625.0 |
| Apr 10, 2024 | 4.60 | 4.79 | 4.50 | 4.71 | 360562.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.4681
Minimum
Nov 09 2023
51.05
Maximum
Jul 02 2020
15.56
Average
9.16
Median
Jul 07 2022
Price Benchmarks
| Roche Holding AG | 31.45 |
| Novartis AG | 103.10 |
| AC Immune SA | 3.54 |
| CRISPR Therapeutics AG | 56.70 |
| Addex Therapeutics Ltd | 9.23 |
Price Related Metrics
| PS Ratio | 4.950 |
| PEG Ratio | -0.1505 |
| Earnings Yield | -66.99% |
| Market Cap | 397.89M |
| PEGY Ratio | -0.1505 |